The newer antimuscarinic drugs: Bladder control with less dry mouth

Rodney A. Appell

Main menu

Home
Content
Specialty
- Articles by Specialty
CME/MOC
- Articles
- Calendar
Info For
Conversations with Leaders
Conference Coverage

Other Publications
- www.clevelandclinic.org

User menu

Search

Search for this keyword

Advanced search

Other Publications
- www.clevelandclinic.org

Search for this keyword

Advanced Search

Home
Content
Specialty
- Articles by Specialty
CME/MOC
- Articles
- Calendar
Info For
Conversations with Leaders
Conference Coverage

Current Drug Therapy

The newer antimuscarinic drugs: Bladder control with less dry mouth

Rodney A. Appell, MD

Cleveland Clinic Journal of Medicine October 2002, 69 (10) 761-769;

Rodney A. Appell

F. Brantley Scott Professor of Voiding Dysfunction, Department of Urology, Baylor College of Medicine, Houston

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: [email protected]

Article
Info & Metrics
PDF

ABSTRACT

Two newer antimuscarinic anticholinergic drugs—tolterodine and extended-release oxybutynin—are approximately as effective in treating overactive bladder as immediate-release oxybutynin, but are more tolerable. I review clinical trial data on the newer agents.

PreviousNext

In this issue

Cleveland Clinic Journal of Medicine

Vol. 69, Issue 10

1 Oct 2002

Table of Contents
Table of Contents (PDF)
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following The newer antimuscarinic drugs: Bladder control with less dry mouth

Message Subject (Your Name) has sent you a message from Cleveland Clinic Journal of Medicine

Message Body (Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

The newer antimuscarinic drugs: Bladder control with less dry mouth

Rodney A. Appell

Cleveland Clinic Journal of Medicine Oct 2002, 69 (10) 761-769;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

The newer antimuscarinic drugs: Bladder control with less dry mouth

Rodney A. Appell

Cleveland Clinic Journal of Medicine Oct 2002, 69 (10) 761-769;

Share This Article:

Tweet Widget
Facebook Like
Linkedin Share Button

Jump to section

Article
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Navigate

Current Issue
Past Issues
Supplements
Article Type
Specialty
CME/MOC Articles
CME/MOC Calendar
Media Kit

Authors & Reviewers

Manuscript Submission
Authors & Reviewers
Subscriptions
About CCJM
Contact Us
Cleveland Clinic Center for Continuing Education
Consult QD

Share your suggestions!

Copyright © 2024 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy.

Main menu

User menu

Search

The newer antimuscarinic drugs: Bladder control with less dry mouth

ABSTRACT

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Navigate

Authors & Reviewers